Irena Adkins

1.4k total citations
32 papers, 1.1k citations indexed

About

Irena Adkins is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Irena Adkins has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Irena Adkins's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Irena Adkins is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Irena Adkins collaborates with scholars based in Czechia, France and United States. Irena Adkins's co-authors include Lenka Sadílková, Radek Špíšek, Peter Šebo, Jiří Mašín, Radim Osička, Jana Kamanová, Ladislav Bumba, Marek Basler, Irena Linhartová and Kateřina Procházková and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Irena Adkins

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Irena Adkins

Since Specialization

Citations

This map shows the geographic impact of Irena Adkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Adkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Adkins more than expected).

Fields of papers citing papers by Irena Adkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Adkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Adkins. The network helps show where Irena Adkins may publish in the future.

Co-authorship network of co-authors of Irena Adkins

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Adkins. A scholar is included among the top collaborators of Irena Adkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Adkins. Irena Adkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity 2022 ·Frontiers in Immunology ·(unknown), (unknown), Jakub Tomala, (unknown), (unknown), (unknown), Milada Šírová, Guy de Martynoff, David Béchard, Ulrich Moebius, Marek Kovář, Radek Špíšek, Irena Adkins	8
2	Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms 2020 ·PLoS ONE ·(unknown), (unknown), Irena Adkins, Zdenĕk Šumnı́k, Lenka Petruželková, Barbora Obermannová, Stanislava Koloušková, Radek Špíšek, Lenka Palová-Jelínková	18
3	Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype 2020 ·Immunology Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Robert Lischke, Radek Špíšek, Irena Adkins	18
4	Radiotherapy in Combination With Cytokine Treatment 2019 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Lenka Sadílková, Lenka Palová Jelínková, Radek Špíšek, Irena Adkins	37
5	High hydrostatic pressure in cancer immunotherapy and biomedicine 2018 ·Biotechnology Advances ·Irena Adkins, (unknown), (unknown), Lenka Sadílková, Lenka Palová-Jelínková, Radek Špíšek	21
6	Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy 2017 ·PLoS ONE ·(unknown), Lenka Sadílková, (unknown), (unknown), (unknown), Robert Lischke, Radek Špíšek, Irena Adkins	25
7	High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy 2017 ·Immunology Letters ·(unknown), (unknown), Irena Moserová, (unknown), Lenka Sadílková, Michal Hensler, Radek Špíšek, Irena Adkins	17
8	Abstract A47: Immunogenic cancer cell death induced by high hydrostatic pressure and hyperthermia: Calreticulin exposure pathway 2017 ·Cancer Research ·(unknown), Irena Adkins, (unknown), (unknown), Lenka Sadílková, Radek Špíšek, Irena Moserová	1
9	Invasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity 2017 ·Toxins ·Giorgio Fedele, Ilaria Schiavoni, Irena Adkins, (unknown), Peter Šebo	36
10	Case-Control Study: Smoking History Affects the Production of Tumor Antigen–Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease–Free Group 2016 ·Journal of Thoracic Oncology ·(unknown), Irena Adkins, (unknown), (unknown), (unknown), (unknown), (unknown), Anna Fialová, Radek Špíšek, Robert Lischke	10
11	Bordetella Adenylate Cyclase Toxin Differentially Modulates Toll-Like Receptor-Stimulated Activation, Migration and T Cell Stimulatory Capacity of Dendritic Cells 2014 ·PLoS ONE ·Irena Adkins, Jana Kamanová, (unknown), (unknown), Jakub Tomala, Hana Jáňová, Jiří Mašín, (unknown), Ladislav Bumba, Marek Kovář, Pádraig J. Ross, Ludmila Tučková, Radek Špíšek, Kingston H. G. Mills, Peter Šebo	24
12	Bacterial Toxins in Cancer Immunotherapy 2013 ·Irena Adkins, Lenka Sadílková, Lenka Palová-Jelínková	1
13	Calcium Influx Rescues Adenylate Cyclase-Hemolysin from Rapid Cell Membrane Removal and Enables Phagocyte Permeabilization by Toxin Pores 2012 ·PLoS Pathogens ·Radovan Fišer, Jiří Mašín, Ladislav Bumba, Eva Pospíšilová, Catherine Fayolle, Marek Basler, Lenka Sadílková, Irena Adkins, Jana Kamanová, Jan Černý, Ivo Konopásek, Radim Osička, Claude Leclerc, Peter Šebo	41
14	Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin 2012 ·Antiviral Research ·(unknown), Irena Adkins, (unknown), (unknown), Peter Šebo, E Varečková	28
15	Bacteria and their Toxins Tamed for Immunotherapy 2012 ·Current Pharmaceutical Biotechnology ·Irena Adkins, (unknown), (unknown), Lenka Sadílková	37
16	In vitro activation of CMV-specific human CD8+ T cells by adenylate cyclase toxoids delivering pp65 epitopes 2011 ·Bone Marrow Transplantation ·Jiří Jelínek, Irena Adkins, Zuzana Mikulková, (unknown), (unknown), (unknown), Peter Šebo, Jaroslav Michálek	7
17	RTX proteins: a highly diverse family secreted by a common mechanism 2010 ·FEMS Microbiology Reviews ·Irena Linhartová, Ladislav Bumba, Jiří Mašín, Marek Basler, Radim Osička, Jana Kamanová, Kateřina Procházková, Irena Adkins, (unknown), Lenka Sadílková, (unknown), Peter Šebo	404
18	Y. enterocolitica inhibits antigen degradation in dendritic cells 2008 ·Microbes and Infection ·Irena Adkins, Martin Köberle, Sabine Gröbner, Stella E. Autenrieth, Erwin Bohn, Stefan Borgmann, Ingo B. Autenrieth	10
19	Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells 2007 ·APOPTOSIS ·Sabine Gröbner, Irena Adkins, Sebastian Schulz, Kathleen Richter, Stefan Borgmann, Sebastian Wesselborg, Klaus Ruckdeschel, Olivier Micheau, Ingo B. Autenrieth	31
20	Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells 2007 ·International Journal of Medical Microbiology ·Irena Adkins, Martin Köberle, Sabine Gröbner, Erwin Bohn, Ingo B. Autenrieth, Stefan Borgmann	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact